AVTXVSCNTX• 3 Months (Normalized)
AVTX vs CNTX (Avalo Therapeutics Inc. vs Context Therapeutics Inc.)
Showing Closing Date Range from Jun, 19 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AVTX Performance $16.69
-2.28%
Avalo Therapeutics Inc.
Normalized Baseline0.00%
CNTX Performance $0.38
-39.14%
Context Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin AVTX LEADS
+36.86%
AVTX outperforming by 36.86%
AVTXCNTX
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AVTX CNTX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | AVTX Price | AVTX Gain (%) | CNTX Price | CNTX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $16.69 | -2.28% | $0.38 | -39.14% | +36.86% |
| Sep 16, 2026 | $16.58 | -2.93% | $0.38 | -39.84% | +36.91% |
| Sep 15, 2026 | $16.07 | -5.91% | $0.36 | -42.22% | +36.31% |
| Sep 14, 2026 | $16.18 | -5.27% | $0.35 | -44.29% | +39.02% |
| Sep 11, 2026 | $16.12 | -5.62% | $0.35 | -44.44% | +38.82% |
| Sep 10, 2026 | $17.18 | +0.59% | $0.37 | -41.90% | +42.49% |
| Sep 09, 2026 | $18.21 | +6.62% | $0.37 | -41.27% | +47.89% |
| Sep 08, 2026 | $19.71 | +15.40% | $0.38 | -40.32% | +55.72% |
| Sep 04, 2026 | $19.23 | +12.59% | $0.36 | -42.54% | +55.13% |
| Sep 03, 2026 | $19.00 | +11.24% | $0.36 | -42.38% | +53.62% |
| Sep 02, 2026 | $19.34 | +13.23% | $0.36 | -42.38% | +55.61% |
| Sep 01, 2026 | $18.95 | +10.95% | $0.36 | -42.22% | +53.17% |
| Aug 31, 2026 | $19.34 | +13.23% | $0.39 | -38.10% | +51.33% |
| Aug 28, 2026 | $19.59 | +14.70% | $0.38 | -39.05% | +53.75% |
| Aug 27, 2026 | $20.05 | +17.39% | $0.42 | -33.97% | +51.36% |
Page 1 of 5